Patients with COVID-19: in the dark-NETs of neutrophils
SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19....
Uloženo v:
| Vydáno v: | Cell death and differentiation Ročník 28; číslo 11; s. 3125 - 3139 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Nature Publishing Group
01.11.2021
|
| Témata: | |
| ISSN: | 1350-9047, 1476-5403, 1476-5403 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19. Individuals that develop severe manifestations have signs of dysregulated innate and adaptive immune responses. Emerging evidence implicates neutrophils and the disbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of inflammation, coagulopathy, organ damage, and immunothrombosis that characterize severe cases of COVID-19. Here, we discuss the evidence supporting a role for NETs in COVID-19 manifestations and present putative mechanisms, by which NETs promote tissue injury and immunothrombosis. We present therapeutic strategies, which have been successful in the treatment of immunο-inflammatory disorders and which target dysregulated NET formation or degradation, as potential approaches that may benefit patients with severe COVID-19. |
|---|---|
| AbstractList | SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19. Individuals that develop severe manifestations have signs of dysregulated innate and adaptive immune responses. Emerging evidence implicates neutrophils and the disbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of inflammation, coagulopathy, organ damage, and immunothrombosis that characterize severe cases of COVID-19. Here, we discuss the evidence supporting a role for NETs in COVID-19 manifestations and present putative mechanisms, by which NETs promote tissue injury and immunothrombosis. We present therapeutic strategies, which have been successful in the treatment of immunο-inflammatory disorders and which target dysregulated NET formation or degradation, as potential approaches that may benefit patients with severe COVID-19.SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19. Individuals that develop severe manifestations have signs of dysregulated innate and adaptive immune responses. Emerging evidence implicates neutrophils and the disbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of inflammation, coagulopathy, organ damage, and immunothrombosis that characterize severe cases of COVID-19. Here, we discuss the evidence supporting a role for NETs in COVID-19 manifestations and present putative mechanisms, by which NETs promote tissue injury and immunothrombosis. We present therapeutic strategies, which have been successful in the treatment of immunο-inflammatory disorders and which target dysregulated NET formation or degradation, as potential approaches that may benefit patients with severe COVID-19. SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19. Individuals that develop severe manifestations have signs of dysregulated innate and adaptive immune responses. Emerging evidence implicates neutrophils and the disbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of inflammation, coagulopathy, organ damage, and immunothrombosis that characterize severe cases of COVID-19. Here, we discuss the evidence supporting a role for NETs in COVID-19 manifestations and present putative mechanisms, by which NETs promote tissue injury and immunothrombosis. We present therapeutic strategies, which have been successful in the treatment of immunο-inflammatory disorders and which target dysregulated NET formation or degradation, as potential approaches that may benefit patients with severe COVID-19. |
| Author | Ackermann, Maximilian Kolaczkowska, Elzbieta van der Vlag, Johan Schett, Georg Radic, Marko Z Bowlin, Gary L Neeli, Indira Knight, Jason S Ng, Lai Guan Mahajan, Aparna Hoffmann, Markus Skendros, Panagiotis Singh, Jeeshan Schapher, Mirco Knopf, Jasmin Vitkov, Ljubomir De Lorenzo, Rebecca Schauer, Christine Yanginlar, Cansu Stark, Konstantin Stürzl, Michael Herrmann, Martin Zarbock, Alexander Kubes, Paul Bilyy, Rostyslav Muñoz, Luis E Henneck, Timo Yousefi, Shida von Köckritz-Blickwede, Maren Hidalgo, Andrés Manfredi, Angelo A Rovere-Querini, Patrizia Simon, Hans-Uwe Maugeri, Norma Daniel, Christoph Mitroulis, Ioannis Maueröder, Christian Kaplan, Mariana J Ritis, Konstantinos Anders, Hans-Joachim Naschberger, Elisabeth Hohberger, Bettina Kanthi, Yogendra Narasaraju, Teluguakula Vandenabeele, Peter Egeblad, Mikala Leppkes, Moritz |
| Author_xml | – sequence: 1 givenname: Maximilian surname: Ackermann fullname: Ackermann, Maximilian organization: Institute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany – sequence: 2 givenname: Hans-Joachim surname: Anders fullname: Anders, Hans-Joachim organization: Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians University Munich, Munich, Germany – sequence: 3 givenname: Rostyslav orcidid: 0000-0002-2344-1349 surname: Bilyy fullname: Bilyy, Rostyslav organization: Danylo Halytsky Lviv National Medical University, Lviv, Ukraine – sequence: 4 givenname: Gary L surname: Bowlin fullname: Bowlin, Gary L organization: Department of Biomedical Engineering, University of Memphis, Memphis, TN, USA – sequence: 5 givenname: Christoph surname: Daniel fullname: Daniel, Christoph organization: Department of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany – sequence: 6 givenname: Rebecca surname: De Lorenzo fullname: De Lorenzo, Rebecca organization: Università Vita-Salute San Raffaele & IRCCS San Raffaele Scientific Institute, Milano, Italy – sequence: 7 givenname: Mikala surname: Egeblad fullname: Egeblad, Mikala organization: Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, NY, USA – sequence: 8 givenname: Timo surname: Henneck fullname: Henneck, Timo organization: Institute for Biochemistry and Research Center for Emerging Infections and Zonoses, University of Veterinary Medicine Hannover, Hannover, Germany – sequence: 9 givenname: Andrés surname: Hidalgo fullname: Hidalgo, Andrés organization: Area of Cell and Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain – sequence: 10 givenname: Markus orcidid: 0000-0001-9698-9922 surname: Hoffmann fullname: Hoffmann, Markus organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 11 givenname: Bettina surname: Hohberger fullname: Hohberger, Bettina organization: Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany – sequence: 12 givenname: Yogendra surname: Kanthi fullname: Kanthi, Yogendra organization: Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA – sequence: 13 givenname: Mariana J orcidid: 0000-0003-2968-0815 surname: Kaplan fullname: Kaplan, Mariana J organization: Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA – sequence: 14 givenname: Jason S surname: Knight fullname: Knight, Jason S organization: Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA – sequence: 15 givenname: Jasmin surname: Knopf fullname: Knopf, Jasmin organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 16 givenname: Elzbieta surname: Kolaczkowska fullname: Kolaczkowska, Elzbieta organization: Department of Experimental Hematology, Institute of Zoology and Biomedical Research, Jagiellonian University, Krakow, Poland – sequence: 17 givenname: Paul surname: Kubes fullname: Kubes, Paul organization: Snyder Institute for Chronic Disease, University of Calgary, Alberta, Canada – sequence: 18 givenname: Moritz surname: Leppkes fullname: Leppkes, Moritz organization: Department of Internal Medicine 1, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 19 givenname: Aparna surname: Mahajan fullname: Mahajan, Aparna organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 20 givenname: Angelo A surname: Manfredi fullname: Manfredi, Angelo A organization: Università Vita-Salute San Raffaele & IRCCS San Raffaele Scientific Institute, Milano, Italy – sequence: 21 givenname: Christian surname: Maueröder fullname: Maueröder, Christian organization: Department of Biomedical Molecular Biology (DBMB), Ghent University, Ghent, Belgium – sequence: 22 givenname: Norma orcidid: 0000-0003-3931-0412 surname: Maugeri fullname: Maugeri, Norma organization: Università Vita-Salute San Raffaele & IRCCS San Raffaele Scientific Institute, Milano, Italy – sequence: 23 givenname: Ioannis surname: Mitroulis fullname: Mitroulis, Ioannis organization: First Department of Internal Medicine, Department of Medicine, University Hospital of Alexandroupolis, and Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis, Greece – sequence: 24 givenname: Luis E orcidid: 0000-0002-5395-804X surname: Muñoz fullname: Muñoz, Luis E organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 25 givenname: Teluguakula surname: Narasaraju fullname: Narasaraju, Teluguakula organization: School of Health Care Administration, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA – sequence: 26 givenname: Elisabeth surname: Naschberger fullname: Naschberger, Elisabeth organization: Division of Molecular and Experimental Surgery, Translational Research Center, Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany – sequence: 27 givenname: Indira surname: Neeli fullname: Neeli, Indira organization: Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA – sequence: 28 givenname: Lai Guan surname: Ng fullname: Ng, Lai Guan organization: Singapore Immunology Network (SIgN), ASTAR, Biopolis, Singapore, Singapore – sequence: 29 givenname: Marko Z orcidid: 0000-0002-8004-282X surname: Radic fullname: Radic, Marko Z organization: Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA – sequence: 30 givenname: Konstantinos surname: Ritis fullname: Ritis, Konstantinos organization: First Department of Internal Medicine, Department of Medicine, University Hospital of Alexandroupolis, and Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis, Greece – sequence: 31 givenname: Patrizia surname: Rovere-Querini fullname: Rovere-Querini, Patrizia organization: Università Vita-Salute San Raffaele & IRCCS San Raffaele Scientific Institute, Milano, Italy – sequence: 32 givenname: Mirco surname: Schapher fullname: Schapher, Mirco organization: Department of Otolaryngology, Friedrich-Alexander-University Erlangen-Nürnberg, Head and Neck Surgery, Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 33 givenname: Christine surname: Schauer fullname: Schauer, Christine organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 34 givenname: Hans-Uwe surname: Simon fullname: Simon, Hans-Uwe organization: Institute of Pharmacology, University of Bern, Inselspital, INO-F, Bern, Switzerland – sequence: 35 givenname: Jeeshan surname: Singh fullname: Singh, Jeeshan organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 36 givenname: Panagiotis surname: Skendros fullname: Skendros, Panagiotis organization: First Department of Internal Medicine, Department of Medicine, University Hospital of Alexandroupolis, and Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis, Greece – sequence: 37 givenname: Konstantin surname: Stark fullname: Stark, Konstantin organization: Medizinische Klinik I, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany – sequence: 38 givenname: Michael orcidid: 0000-0002-9276-2824 surname: Stürzl fullname: Stürzl, Michael organization: Division of Molecular and Experimental Surgery, Translational Research Center, Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany – sequence: 39 givenname: Johan orcidid: 0000-0001-7843-5918 surname: van der Vlag fullname: van der Vlag, Johan organization: Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands – sequence: 40 givenname: Peter orcidid: 0000-0002-6669-8822 surname: Vandenabeele fullname: Vandenabeele, Peter organization: Department of Biomedical Molecular Biology (DBMB) and Methusalem Program, Ghent University, Ghent, Belgium – sequence: 41 givenname: Ljubomir orcidid: 0000-0002-1249-0161 surname: Vitkov fullname: Vitkov, Ljubomir organization: Clinic of Operative Dentistry, Periodontology and Preventive Dentistry, Saarland University, Homburg, Germany – sequence: 42 givenname: Maren orcidid: 0000-0001-7712-9767 surname: von Köckritz-Blickwede fullname: von Köckritz-Blickwede, Maren organization: Institute for Biochemistry and Research Center for Emerging Infections and Zonoses, University of Veterinary Medicine Hannover, Hannover, Germany – sequence: 43 givenname: Cansu surname: Yanginlar fullname: Yanginlar, Cansu organization: Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands – sequence: 44 givenname: Shida orcidid: 0000-0002-9855-4305 surname: Yousefi fullname: Yousefi, Shida organization: Institute of Pharmacology, University of Bern, Inselspital, INO-F, Bern, Switzerland – sequence: 45 givenname: Alexander surname: Zarbock fullname: Zarbock, Alexander organization: Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany – sequence: 46 givenname: Georg orcidid: 0000-0001-8740-9615 surname: Schett fullname: Schett, Georg organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany – sequence: 47 givenname: Martin orcidid: 0000-0002-0258-2484 surname: Herrmann fullname: Herrmann, Martin email: martin.herrmann@uk-erlangen.de, martin.herrmann@uk-erlangen.de organization: Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany. martin.herrmann@uk-erlangen.de |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34031543$$D View this record in MEDLINE/PubMed |
| BookMark | eNpd0E1Lw0AQBuBFKvZD_4AHCXjxsjqzH9ldb1KrFooVLF5D0szS1DSp2QTRX2_AevE0A_MwzLxjNqjqihg7R7hGkPYmKFRoOQjkABY0_z5iI1Qm5lqBHPS91MAdKDNk4xC2ABAbF5-woeznqJUcMfOStgVVbYg-i3YTTZdv83uO7jYqqqjdUJSnzTt_nq1CVPuooq5t6v2mKMMpO_ZpGejsUCfs9WG2mj7xxfJxPr1b8LUyquWU-7XNnUmByPjMk9RCasJMCxTWQGZd5pX2LgfMTZaj05Q5BOul8FpO2NXv1n1Tf3QU2mRXhDWVZVpR3YVEaCmEUtphTy__0W3dNVV_W68c2rh_Wfbq4qC6bEd5sm-KXdp8JX-ByB9922Gw |
| CitedBy_id | crossref_primary_10_1371_journal_pone_0273969 crossref_primary_10_3389_fimmu_2022_835156 crossref_primary_10_3389_fimmu_2021_712948 crossref_primary_10_1186_s12889_023_17477_8 crossref_primary_10_1515_cclm_2022_0574 crossref_primary_10_3390_diagnostics12020509 crossref_primary_10_1016_j_intimp_2024_112085 crossref_primary_10_3390_jcm11071800 crossref_primary_10_1177_03009858211071012 crossref_primary_10_3389_fimmu_2022_872695 crossref_primary_10_1038_s41467_024_55272_0 crossref_primary_10_3390_immuno3010007 crossref_primary_10_1096_fj_202301316R crossref_primary_10_1016_j_heliyon_2024_e30760 crossref_primary_10_2478_rir_2022_0002 crossref_primary_10_1038_s41392_023_01580_8 crossref_primary_10_1016_j_heliyon_2023_e16982 crossref_primary_10_1158_2326_6066_CIR_22_0197 crossref_primary_10_3389_fcimb_2025_1587321 crossref_primary_10_1016_j_thromres_2022_08_017 crossref_primary_10_1002_iid3_949 crossref_primary_10_3390_jcm11144152 crossref_primary_10_3389_fimmu_2023_1270414 crossref_primary_10_3390_cells10081891 crossref_primary_10_3389_fcimb_2022_988604 crossref_primary_10_1002_ptr_70025 crossref_primary_10_1016_j_smim_2022_101644 crossref_primary_10_1016_j_heliyon_2023_e17958 crossref_primary_10_3389_fphar_2022_899198 crossref_primary_10_1126_scitranslmed_adn7527 crossref_primary_10_3389_fimmu_2022_864298 crossref_primary_10_1038_s41598_022_11157_0 crossref_primary_10_3389_fimmu_2023_1146612 crossref_primary_10_1002_path_5860 crossref_primary_10_3390_v15010175 crossref_primary_10_5582_bst_2023_01039 crossref_primary_10_1083_jcb_202203083 crossref_primary_10_3390_life12020153 crossref_primary_10_3389_fonc_2022_869706 crossref_primary_10_1159_000543633 crossref_primary_10_1186_s12014_022_09377_7 crossref_primary_10_1007_s00296_024_05596_3 crossref_primary_10_3390_ijms26104773 crossref_primary_10_1002_rth2_12808 crossref_primary_10_1146_annurev_pathmechdis_051222_015009 crossref_primary_10_1111_1348_0421_12978 crossref_primary_10_3390_ijms232112855 crossref_primary_10_1016_j_isci_2023_108289 crossref_primary_10_3390_cells10092208 crossref_primary_10_3390_ph16040584 crossref_primary_10_1007_s43440_022_00394_9 crossref_primary_10_2147_JBM_S365218 crossref_primary_10_3390_ijms23063195 crossref_primary_10_1097_MD_0000000000039566 crossref_primary_10_1016_j_imlet_2021_12_001 crossref_primary_10_3389_fmolb_2023_1158133 crossref_primary_10_1016_j_jacbts_2024_12_004 crossref_primary_10_3390_ijms25073787 crossref_primary_10_1515_cclm_2022_0936 crossref_primary_10_3390_ijms232113656 crossref_primary_10_3390_ijms25168757 crossref_primary_10_1016_j_cclet_2024_110238 crossref_primary_10_1186_s13287_022_02796_1 crossref_primary_10_1093_jleuko_qiae195 crossref_primary_10_3389_fimmu_2023_1113948 crossref_primary_10_3389_fimmu_2022_996637 crossref_primary_10_1055_s_0041_1741418 crossref_primary_10_1038_s41420_021_00671_1 crossref_primary_10_1186_s41231_023_00143_x crossref_primary_10_1186_s12985_023_02116_w crossref_primary_10_1016_S2213_2600_22_00261_2 crossref_primary_10_3390_cells14151151 crossref_primary_10_1038_s41522_025_00691_0 crossref_primary_10_2147_IDR_S450318 crossref_primary_10_3389_fpubh_2023_1161881 crossref_primary_10_3389_fmed_2022_1052921 crossref_primary_10_1002_JLB_1MR1221_345R crossref_primary_10_15557_PiMR_2024_0039 crossref_primary_10_3390_microorganisms9102036 crossref_primary_10_1038_s41392_024_01933_x crossref_primary_10_1093_ofid_ofaf199 crossref_primary_10_1109_ACCESS_2023_3308225 crossref_primary_10_4049_jimmunol_2200173 crossref_primary_10_1016_j_jff_2024_106272 crossref_primary_10_3389_fmed_2021_676554 crossref_primary_10_1016_j_jtauto_2025_100280 crossref_primary_10_1182_blood_2021013440 crossref_primary_10_1002_jbm4_10576 crossref_primary_10_1016_j_jccase_2025_01_001 crossref_primary_10_3389_fcell_2022_945749 crossref_primary_10_1371_journal_pone_0295268 crossref_primary_10_1016_j_jconrel_2025_113736 crossref_primary_10_1007_s11239_024_03057_z crossref_primary_10_1007_s10534_022_00458_6 crossref_primary_10_1182_blood_2024027599 crossref_primary_10_3390_biom13010082 crossref_primary_10_3389_fimmu_2025_1547918 crossref_primary_10_1073_pnas_2211065119 crossref_primary_10_3389_fcvm_2022_951670 crossref_primary_10_3390_cardiogenetics14010004 crossref_primary_10_1093_jleuko_qiaf078 crossref_primary_10_1016_j_ejcb_2024_151407 crossref_primary_10_1007_s11357_022_00724_y crossref_primary_10_1186_s12967_022_03737_5 crossref_primary_10_3389_fimmu_2022_904419 crossref_primary_10_1111_1346_8138_16673 crossref_primary_10_1007_s41939_023_00292_4 crossref_primary_10_3390_ijms232012514 crossref_primary_10_3389_fimmu_2023_1185233 crossref_primary_10_1007_s10534_022_00432_2 crossref_primary_10_3389_fimmu_2022_1030610 crossref_primary_10_21508_1027_4065_2025_70_1_18_25 crossref_primary_10_3389_fimmu_2023_1225210 crossref_primary_10_1002_bem_22406 crossref_primary_10_3390_biomedicines10030702 crossref_primary_10_1038_s41598_023_42167_1 crossref_primary_10_1016_j_jtha_2023_06_005 crossref_primary_10_3389_fimmu_2022_838011 crossref_primary_10_3389_fmed_2021_754667 crossref_primary_10_1016_j_biopha_2023_114530 crossref_primary_10_1182_blood_2021011234 crossref_primary_10_1111_bjh_18095 crossref_primary_10_1186_s12964_025_02181_4 crossref_primary_10_3389_fimmu_2023_1031336 crossref_primary_10_3390_biom14020236 crossref_primary_10_3390_biomedicines13092232 crossref_primary_10_1016_j_eclinm_2025_103358 crossref_primary_10_1016_j_clim_2022_109016 crossref_primary_10_1177_10760296241255959 crossref_primary_10_1038_s41418_022_01015_x crossref_primary_10_3390_vaccines9060597 crossref_primary_10_3389_fcell_2021_770463 crossref_primary_10_1016_j_lfs_2022_121334 crossref_primary_10_3389_fcvm_2022_1026866 crossref_primary_10_3389_fimmu_2022_870216 crossref_primary_10_3390_jcm12020601 crossref_primary_10_1016_j_jiac_2025_102666 crossref_primary_10_3390_ijms26188756 crossref_primary_10_1016_j_pharmthera_2025_108917 crossref_primary_10_3390_biomedicines9121867 crossref_primary_10_1186_s12931_025_03180_2 crossref_primary_10_1016_j_jcyt_2021_12_003 crossref_primary_10_1007_s10456_024_09910_2 crossref_primary_10_3389_fimmu_2023_1254310 crossref_primary_10_3390_biomedicines11030929 crossref_primary_10_1016_j_intimp_2025_114934 crossref_primary_10_3390_ijms251810054 crossref_primary_10_1371_journal_pone_0267235 crossref_primary_10_3389_fimmu_2022_902206 crossref_primary_10_1097_MCC_0000000000001303 crossref_primary_10_1007_s00423_022_02495_8 crossref_primary_10_1186_s13054_022_04062_5 crossref_primary_10_3390_cells13110991 crossref_primary_10_1177_1721727X231210425 crossref_primary_10_3390_biology14081056 crossref_primary_10_4049_jimmunol_2100855 crossref_primary_10_3389_fimmu_2022_1011185 crossref_primary_10_1172_JCI163105 crossref_primary_10_1042_BCJ20210602 crossref_primary_10_1016_j_biopha_2022_112718 crossref_primary_10_1039_D4LC00848K crossref_primary_10_2147_IDR_S342259 crossref_primary_10_62347_TSPM9335 crossref_primary_10_3390_ph15050616 crossref_primary_10_1186_s12931_023_02650_9 crossref_primary_10_1177_08828245251362439 crossref_primary_10_3390_ijms23137209 crossref_primary_10_3390_app142311048 crossref_primary_10_3390_healthcare9080956 crossref_primary_10_3389_fimmu_2022_835104 crossref_primary_10_1186_s12929_024_01026_5 crossref_primary_10_1016_j_mrrev_2025_108550 crossref_primary_10_1080_22221751_2022_2122579 crossref_primary_10_1007_s12016_021_08912_y crossref_primary_10_2147_JIR_S504028 crossref_primary_10_1038_s41586_022_04702_4 crossref_primary_10_1093_cvr_cvad084 crossref_primary_10_1016_j_jpha_2022_10_003 crossref_primary_10_1084_jem_20220011 crossref_primary_10_1155_2022_7411824 crossref_primary_10_3389_fimmu_2021_775267 crossref_primary_10_3390_ijms24032646 crossref_primary_10_1097_MD_0000000000033806 crossref_primary_10_1016_j_ajog_2022_03_048 crossref_primary_10_1111_jth_15575 crossref_primary_10_1155_2023_6685251 crossref_primary_10_3389_fimmu_2024_1378591 crossref_primary_10_3390_cells11172619 crossref_primary_10_3390_v17091198 crossref_primary_10_1089_sur_2023_156 crossref_primary_10_3390_cells11182889 crossref_primary_10_1016_j_path_2023_01_007 crossref_primary_10_3390_biom14091078 crossref_primary_10_3389_fimmu_2021_719023 crossref_primary_10_1007_s10238_024_01351_x crossref_primary_10_1016_j_ijbiomac_2025_141026 crossref_primary_10_1093_jleuko_qiae025 |
| ContentType | Journal Article |
| Copyright | 2021. The Author(s). The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2021. The Author(s). – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7TK 7TM 7X7 7XB 88A 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 |
| DOI | 10.1038/s41418-021-00805-z |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Central Student MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1476-5403 |
| EndPage | 3139 |
| ExternalDocumentID | 34031543 |
| Genre | Research Support, N.I.H., Intramural Review Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Deutsche Forschungsgemeinschaft (German Research Foundation) grantid: TRR241: B04 – fundername: Deutsche Forschungsgemeinschaft (German Research Foundation) grantid: CRC1181: C03 – fundername: NHLBI NIH HHS grantid: K08 HL131993 – fundername: NHLBI NIH HHS grantid: R01 HL150392 – fundername: EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) grantid: 4D Nanoscope |
| GroupedDBID | --- -Q- 0R~ 29B 2WC 36B 39C 4.4 406 53G 5GY 70F 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AACDK AAHBH AANZL AASDW AASML AATNV AAYZH ABAKF ABAWZ ABBRH ABDBE ABDBF ABFSG ABJNI ABLJU ABRTQ ABUWG ABZZP ACAOD ACGFS ACIWK ACKTT ACPRK ACRQY ACSTC ACUHS ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI C1A CAG CCPQU CGR COF CS3 CUY CVF DIK DNIVK DPUIP DU5 E3Z EAD EAP EBC EBD EBLON EBS ECM EE. EIF EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IWAJR JSO JZLTJ KQ8 L7B LK8 M1P M7P NPM NQJWS OK1 P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X RIG RNS RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 TSG TUS UKHRP ~8M 3V. 7QP 7QR 7T5 7TK 7TM 7XB 88A 8FD 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 7X8 PUEGO |
| ID | FETCH-LOGICAL-c474t-edfc8d97a0ee7fbfe35235e1b5212870b89bf45f9d01d7bd195eb9108f32f53 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 231 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000653830300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1350-9047 1476-5403 |
| IngestDate | Thu Oct 02 11:29:34 EDT 2025 Tue Oct 07 05:21:42 EDT 2025 Mon Jul 21 05:55:54 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Language | English |
| License | 2021. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c474t-edfc8d97a0ee7fbfe35235e1b5212870b89bf45f9d01d7bd195eb9108f32f53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-7843-5918 0000-0002-2344-1349 0000-0001-8740-9615 0000-0001-9698-9922 0000-0002-1249-0161 0000-0002-5395-804X 0000-0002-8004-282X 0000-0003-2968-0815 0000-0003-3931-0412 0000-0002-9855-4305 0000-0002-9276-2824 0000-0001-7712-9767 0000-0002-6669-8822 0000-0002-0258-2484 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8142290 |
| PMID | 34031543 |
| PQID | 2591864033 |
| PQPubID | 44124 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_2532244591 proquest_journals_2591864033 pubmed_primary_34031543 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-11-01 |
| PublicationDateYYYYMMDD | 2021-11-01 |
| PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Rome |
| PublicationTitle | Cell death and differentiation |
| PublicationTitleAlternate | Cell Death Differ |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group |
| SSID | ssj0006796 |
| Score | 2.697987 |
| SecondaryResourceType | review_article |
| Snippet | SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 3125 |
| SubjectTerms | Adaptive immunity Citrullination Complement Activation Coronaviruses COVID-19 COVID-19 - complications COVID-19 - immunology COVID-19 - pathology Extracellular Traps - metabolism Humans Immune response Inflammatory diseases Leukocytes (neutrophilic) Neutrophils Neutrophils - immunology Neutrophils - metabolism Pandemics Patients Platelet Activation SARS-CoV-2 - isolation & purification Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Thrombosis - etiology |
| Title | Patients with COVID-19: in the dark-NETs of neutrophils |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34031543 https://www.proquest.com/docview/2591864033 https://www.proquest.com/docview/2532244591 |
| Volume | 28 |
| WOSCitedRecordID | wos000653830300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NT9swFH8aH0Nc-OgGFFhlpF0tktqubS4IuqJNoiHaKtRbFce2VoGS0rRI8NdjJwZO24WLL3myoufnl1_e1w_gu9BK57ZnsAMbBlMbKaxorHFGfCaxl9G8rqq8veZJIsZjmYaAWxXKKl99Yu2odZn7GPmpg-mx6NGIkPPZA_asUT67Gig0VmDNTypzdr52OUjS32--2EdJ6l8uFmEZUR7aZiIiTisa01hgX6LgYRPDz_8GmfXH5mr7o6-5A1sBZqKLxi524ZMpWvC5IZ58asHGMKTUvwBPm8mqFfIhWdS_uf31A8fyDE0L5MAh0tn8DieDUYVKiwqzXMzL2d_pffUV_lwNRv2fOLAp4JxyusBG21xoybPIGG6VNQ56EWZi5bt33a1VQipLmZU6ijVXOpbMKAcmhCVdy8gerBZlYQ4ARTyTrJspbjRzR8mk4IoKJ6kM4aSXteH4VTWTcCGqybte2nDy9tiZss9PZIUpl17GeRdKnWQb9hv1T2bNzI0JoZ6OgpLD_29-BJtdf6J1s-AxrC7mS_MN1vPHxbSad2CFj3m9ik6wlI4v9kzdmqTDF6XJw7w |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1dT9swFL1CfL-MDRh0K5uR4NHCiZ3anoTQVEBUlFKJCvFEFMe2VoGS0rQg9pv2I2cnKTxtbzzwnKsoyj2-Pr4fPgB7Qiud2pbBjmwYzCxRWLFA44T6SmIrYWnZVXnd5b2euLmR_Tn4M5uF8W2Vs5hYBmqdpz5HfuBoeiBajFB6NHrAXjXKV1dnEhoVLM7N85M7shWHnWPn3_0wPD0ZtM9wrSqAU8bZBBttU6ElT4gx3CprHAWhkQmUn2J16FVCKssiKzUJNFc6kJFRblMVlobWa0S4gL_gSERIykbB_kvc9xmZ8ngXESwJ4_WIDqHioGABCwT27RCeokX4978Jbbmxna69r1_yET7UBBr9rBD_CeZMtg5LlaTm8zosX9TNAhvA-9WdsQXyyWbUvrzuHONA_kDDDDnai3QyvsO9k0GBcosyM52M89Gv4X2xCVdv8PmfYT7LM7MNiPBERmGiuNGRA2kkBVdMOEtlKKetpAHNmSPieqkX8asXGrD78tgtUl95STKTT72Ni5uMOcsGbFXOjkfVbSIxZV5og9Ev_3_5d1g5G1x0426nd_4VVkOPpXIksgnzk_HU7MBi-jgZFuNvJSoR3L6tx_8CpiAbYA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patients+with+COVID-19%3A+in+the+dark-NETs+of+neutrophils&rft.jtitle=Cell+death+and+differentiation&rft.au=Ackermann+Maximilian&rft.au=Anders%2C+Hans-Joachim&rft.au=Bilyy+Rostyslav&rft.au=Bowlin%2C+Gary+L&rft.date=2021-11-01&rft.pub=Nature+Publishing+Group&rft.issn=1350-9047&rft.eissn=1476-5403&rft.volume=28&rft.issue=11&rft.spage=3125&rft.epage=3139&rft_id=info:doi/10.1038%2Fs41418-021-00805-z |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1350-9047&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1350-9047&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1350-9047&client=summon |